Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oral phenoxodiol evaluated in phase I trial for cervical cancer

Feb. 25, 2004

Thalomid sNDA accepted for review

Feb. 25, 2004

Novel antiproliferative agents in early development at Bayer

Feb. 25, 2004

New mitotic kinesin KSP inhibitors jointly reported by Cytokinetics and GSK

Feb. 25, 2004

New macrolide-containing conjugates and their use reported by Pliva

Feb. 25, 2004

Inflammation and elevated C-reactive protein increase the risk of colon cancer

Feb. 25, 2004

New antitumor fredericamycin derivatives discovered at Biofrontera

Feb. 24, 2004

Novartis presents novel tyrosine kinase inhibitors with utility in leukemia

Feb. 24, 2004

New protein kinase inhibitors for cancer therapy designed at Novartis

Feb. 24, 2004

Phase I trial of PT-523 commences enrollment

Feb. 24, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...